Milestone scientific inc. (MLSS)
Balance Sheet / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Dec'10
Current assets:
Cash and cash equivalents

765

1,516

1,711

2,337

2,739

743

414

865

2,094

2,636

2,307

2,945

2,941

3,602

2,322

3,183

2,671

4,194

4,390

1,447

9,331

10,367

781

1,121

1,398

1,147

401

171

121

165

273

121

112

96

370

98

627

Treasury Bills

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,550

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Treasury bills

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

9,499

9,498

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable, net

1,289

1,710

1,239

1,658

1,512

1,978

1,014

1,840

833

1,535

1,999

1,419

1,626

802

2,553

2,583

2,269

1,437

2,349

1,635

1,642

1,541

1,624

1,443

1,221

1,532

1,570

1,061

1,319

978

794

1,081

1,069

1,154

1,043

1,685

796

Accounts receivable, related party, net

-

-

-

-

50

100

1,258

2,817

1,725

1,725

712

356

682

2,714

-

-

-

356

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other receivable

-

-

-

-

-

-

-

-

-

-

0

0

0

10

0

67

58

58

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note receivable from financing transaction, current

-

-

-

-

-

-

0

0

500

500

500

500

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

707

519

504

406

595

414

446

484

494

436

552

746

509

291

276

375

505

304

428

469

691

454

-

-

-

150

-

-

-

-

-

-

-

-

-

-

-

Deferred cost, related party

-

-

-

-

24

50

790

1,796

1,109

1,109

362

181

181

620

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Due from related party

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

85

343

184

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note receivable-Milestone Medical Inc

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,000

1,000

200

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Receivable from Milestone Medical Inc

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

132

-

-

-

-

-

-

-

-

-

-

Inventories, net

1,722

1,620

1,617

1,270

1,861

1,921

2,245

2,310

3,265

3,379

4,165

4,498

4,533

4,602

4,319

4,268

3,898

4,258

2,804

3,240

2,766

2,497

2,241

1,964

1,744

1,321

874

857

625

638

670

514

589

790

733

597

986

Advances on contracts

775

710

628

530

530

648

884

861

984

697

992

851

862

700

1,268

1,215

1,253

1,215

1,211

723

252

721

1,092

1,454

1,763

727

501

508

429

476

940

940

940

952

728

728

730

Prepaid expenses and other current assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

370

161

242

-

116

161

165

239

150

297

297

304

236

280

247

Total current assets

5,261

6,093

5,755

6,296

7,314

5,856

7,055

10,976

11,007

12,020

11,592

11,499

11,337

13,344

10,740

11,693

10,656

11,824

13,271

14,409

15,068

15,582

15,610

15,644

6,371

4,879

3,597

2,759

2,662

2,498

2,829

2,955

3,009

3,298

3,112

3,390

3,388

Advances on contracts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,580

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable-long term, net of allowance for doubtful accounts of $167,971 in 2012

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

81

119

164

206

230

261

257

257

361

Advances on contracts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

218

218

218

-

2,052

2,163

2,358

2,350

2,150

2,294

2,358

2,453

2,606

2,646

1,713

Investment in Milestone Medical Inc

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

619

760

852

-

-

-

-

-

76

76

76

76

76

76

76

Investment in Milestone Education LLC

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

34

38

-

50

50

50

-

-

-

46

124

185

-

0

Furniture, fixtures and equipment, net

29

44

55

65

77

82

94

105

115

141

119

170

142

159

181

201

220

235

115

117

85

88

77

38

24

23

26

30

33

36

40

44

47

52

56

62

66

Patents, net

369

382

395

408

422

435

448

2,320

2,552

2,789

3,152

625

642

660

678

695

712

715

480

495

512

530

532

552

572

591

607

626

638

648

662

673

689

698

713

924

944

Right of use asset

649

15

54

92

129

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Note receivable from financing transaction, noncurrent

-

-

-

-

-

-

0

0

650

650

650

775

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other assets

24

35

35

17

17

26

26

26

26

26

26

26

26

17

17

11

17

17

17

17

14

14

12

12

12

12

12

7

7

7

7

9

20

27

38

24

57

Total assets

6,374

6,556

6,242

6,788

7,961

6,400

7,625

13,429

14,352

15,628

15,541

13,096

12,149

14,181

11,618

12,602

11,606

12,809

14,064

15,340

16,653

17,477

17,269

17,261

8,090

8,055

6,347

5,637

5,830

5,661

5,931

6,260

6,477

6,992

7,046

7,382

6,609

Current liabilities:
Accounts payable

1,443

1,379

739

1,192

1,198

1,059

1,306

1,365

1,556

977

616

985

889

1,341

2,273

2,497

1,866

2,088

780

795

1,229

1,453

1,340

983

1,217

2,020

1,806

1,505

2,030

2,336

2,605

3,085

3,407

3,931

2,704

2,889

2,883

Accounts payable, related party

1,389

1,358

1,553

1,283

1,400

1,810

1,453

1,352

1,075

985

902

381

1,082

1,235

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other payables

832

775

698

1,464

1,548

794

2,003

1,937

1,928

2,179

2,162

1,652

1,294

1,436

1,741

1,492

1,375

1,555

1,350

-

-

981

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses, related party

1,162

1,057

1,011

125

110

686

64

-

-

108

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Lease liabilities, current

65

15

54

92

114

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred profit, related party

340

340

372

372

431

421

492

636

714

751

659

659

-

630

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, related party

-

-

-

-

50

100

-

-

-

1,725

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative liability

-

-

3,216

1,418

365

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, related party

-

-

-

-

-

-

1,258

2,817

1,725

-

712

356

356

1,001

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other payables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,143

627

-

-

-

-

515

-

-

-

-

-

-

-

-

-

-

-

Customer advances

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

49

209

507

-

-

-

-

-

-

-

-

-

-

-

-

Accrued expenses and other payables

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

610

754

484

-

747

614

551

581

915

833

766

407

883

1,069

511

Accrued interest on Notes Payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

405

380

356

-

-

-

269

-

-

-

Total current liabilities

5,240

4,927

7,647

5,950

5,219

4,872

6,579

8,109

7,000

6,728

5,053

4,035

3,622

5,645

-

-

-

3,643

-

1,939

1,856

-

2,000

1,947

2,208

2,535

2,553

2,525

2,962

3,274

3,520

3,919

4,173

4,608

3,588

3,959

3,394

Lease liability, non-current

612

-

-

-

15

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred gain from financing transaction

-

-

-

-

-

-

0

0

1,400

1,400

1,400

1,400

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total liabilities

5,886

4,927

7,647

5,950

5,235

4,872

6,579

8,109

8,400

8,128

6,453

5,435

-

5,645

-

-

-

-

-

-

-

-

-

-

-

2,535

2,553

2,975

3,412

-

-

-

-

-

-

-

-

Accounts payable -- long term

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

877

868

440

Notes payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

450

450

450

450

450

448

446

445

443

441

Total long-term liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

450

450

450

450

450

448

446

1,322

1,312

882

Commitments and contingencies

-

-

-

-

-

-

0

0

0

-

0

0

0

0

-

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

0

-

0

-

-

-

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

381

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,396

3,990

3,241

-

2,131

-

-

2,435

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stockholders’ equity
Series A convertible preferred stock, par value $.001, authorized 5,000,000 shares, 0 and 7,000 shares issued and outstanding as of December 31, 2019 and 2018.

-

-

-

-

0

0

0

0

0

0

0

0

0

0

0

-

-

0

-

-

-

-

-

-

0

-

-

-

-

0

-

-

-

-

-

-

-

Common stock, par value $.001; authorized 75,000,000 shares; 49,893,534 shares issued and 49,376,843 shares outstanding as of March 31, 2020; 49,410,176 shares issued and 49,376,843 shares outstanding as of December 31, 2019;

49

49

48

47

43

36

35

35

34

34

34

32

32

31

29

28

22

22

22

22

22

22

22

21

19

19

19

18

18

18

17

17

17

17

16

15

15

Additional paid in capital

96,553

96,082

90,166

89,559

90,398

88,414

87,971

87,832

87,115

86,689

86,442

83,600

83,329

82,761

79,477

79,126

79,076

78,632

78,016

77,908

77,586

77,504

76,757

76,443

66,844

66,677

65,973

65,060

64,890

64,560

64,219

64,164

63,965

63,690

63,485

62,823

62,606

Accumulated deficit

-95,124

-93,524

-90,660

-87,823

-86,782

-85,999

-86,179

-81,784

-80,442

-78,568

-76,778

-75,365

-73,886

-73,381

-71,642

-69,813

-68,185

-67,434

-66,028

-64,459

-62,386

-61,967

-60,598

-60,240

-60,070

-60,265

-61,287

-61,505

-61,579

-61,730

-61,364

-61,379

-61,215

-60,860

-60,455

-59,817

-59,377

Treasury stock, at cost, 33,333 shares

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

911

Total Milestone Scientific Inc. stockholders' equity

567

1,695

-1,357

871

2,748

1,539

915

5,171

5,796

7,243

8,787

7,356

8,564

8,500

6,952

8,429

10,003

10,308

11,098

12,560

14,310

14,647

15,269

15,314

5,882

5,519

3,793

2,662

2,417

1,936

1,961

1,891

1,855

1,936

2,135

2,110

2,332

Noncontrolling interest

-80

-67

-46

-33

-21

-11

130

148

155

256

300

304

-37

36

269

181

-1,637

-1,143

834

840

486

394

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total stockholders’ equity

487

1,628

-1,404

837

2,726

1,528

1,045

5,319

5,951

7,500

9,087

7,661

8,527

8,536

7,221

8,611

8,365

9,165

11,932

13,400

14,796

15,042

-

-

-

5,519

-

-

-

-

-

-

-

-

-

-

-

Total liabilities and stockholders’ equity

6,374

6,556

6,242

6,788

7,961

6,400

7,625

13,429

14,352

15,628

15,541

13,096

12,149

14,181

11,618

12,602

11,606

12,809

14,064

15,340

16,653

17,477

17,269

17,261

8,090

8,055

6,347

5,637

5,830

5,661

5,931

6,260

6,477

6,992

7,046

7,382

6,609